Earnings Feed
Start Free
ABIOMED INC·4

Jul 17, 4:28 PM ET

ABIOMED INC 4

4 · ABIOMED INC · Filed Jul 17, 2013

Insider Transaction Report

Form 4
Period: 2013-07-15
ABIOMED INCABMD
Bowen Robert
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock, $.01 par value

    2013-07-15$5.86/sh+40,786$239,006→ 107,715 total
  • Sale

    Common Stock, $.01 par value

    2013-07-15$23.50/sh−40,786$958,471→ 66,929 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-07-15−40,786→ 0 total
    Exercise: $5.86From: 2010-05-28Exp: 2019-05-28→ Common Stock (40,786 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $23.15From: 2014-05-14Exp: 2024-05-14→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (right to buy)

    Exercise: $5.86From: 2010-03-31Exp: 2019-05-28→ Common Stock (30,000 underlying)
    30,000

  • Stock Option (Right to Buy)

    Exercise: $15.92From: 2009-12-22Exp: 2018-12-22→ Common Stock (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $10.03From: 2011-06-03Exp: 2020-06-03→ Common Stock (15,000 underlying)
    15,000

  • Stock Option (right to buy)

    Exercise: $22.44From: 2013-05-22Exp: 2022-05-22→ Common Stock (20,000 underlying)
    20,000
Footnotes (3)
  • [F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
  • [F2]These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
  • [F3]Sale of common stock pursuant to reporting owner's 10b5-1 plan.

Documents

2 files